Annual ROE
23.06%23.31%-50.27%
Summary
- Current Value
- As of today, GSK annual ROE is 23.06%, down -50.27% on
- Historical Performance
- GSK annual ROE is up +36.77% over the past 3 years, and down -50.26% over the past 5 years
- All-Time High Comparison
- GSK annual ROE is currently -90.95% below its historical high of 254.91% set on
- 3-Year Low Comparison
- GSK annual ROE is at its 3-year low
- Sector Comparison
- GSK annual ROE is higher than 86.77% of companies in Healthcare sector
ROE Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual ROE | 23.06% | -50.3% | +36.8% | -50.3% | -62.0% | |
| Quarterly ROE | 42.84% | +99.9% | +94.4% | +17.5% | +5.2% | |
| Price | $50.22 | +48.8% | +43.8% | +28.5% | +27.1% | |
| PE Ratio | 14.32 | -32.9% | +260.7% | +33.2% | -55.0% | |
| Annual Revenue | $40.09B | +6.3% | +18.0% | -6.9% | -9.9% | |
| Annual Net Income | $3.77B | -42.9% | -22.0% | -43.9% | -57.6% | |
| Annual Shareholders Equity | $17.12B | +0.6% | -16.0% | +13.3% | +6.0% | |
| Annual ROA | 5.04% | -43.6% | +13.0% | -32.7% | -64.4% |
ROE Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | 46.37% | -50.3% | |
| 5Y | 46.37% | -50.3% | |
| All | 254.91% | -91.0% |
ROE Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | 23.06% | at low | |
| 5Y | 16.86% | +36.8% | |
| All | 14.87% | +55.1% |
ROE History
FAQ
What is the current annual ROE of GSK?
As of today, GSK annual ROE is 23.06%
What is 1-year change in GSK annual ROE?
GSK annual ROE is down -50.27% year-over-year
What is 3-year change in GSK annual ROE?
GSK annual ROE is up +36.77% over the past 3 years
How far is GSK annual ROE from its all-time high?
GSK annual ROE is currently -90.95% below its historical high of 254.91% set on December 31, 1996
How does GSK annual ROE rank versus sector peers?
GSK annual ROE is higher than 86.77% of companies in Healthcare sector
When is GSK next annual earnings release?
The next annual earnings release for GSK is on
Quarterly ROE
42.84%13.91%+48.08%
Summary
- Current Value
- As of today, GSK quarterly ROE is 42.84%, up +48.08% on
- Historical Performance
- GSK quarterly ROE is up +99.91% year-over-year, and up +94.37% over the past 3 years
- All-Time High Comparison
- GSK quarterly ROE is currently -83.19% below its historical high of 254.79% set on
- 3-Year Low Comparison
- GSK quarterly ROE is +99.91% above its 3-year low of 21.43% reached on
- Sector Comparison
- GSK quarterly ROE is higher than 88.87% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly ROE | 42.84% | +48.1% | +99.9% | +94.4% | +17.5% | |
| Annual ROE | 23.06% | – | -50.3% | +36.8% | -50.3% | |
| Price | $50.22 | +15.8% | +48.8% | +43.8% | +28.5% | |
| PE Ratio | 14.32 | +15.9% | -32.9% | +260.7% | +33.2% | |
| Quarterly Revenue | $11.52B | +8.0% | +10.6% | +25.2% | +3.2% | |
| Quarterly Net Income | $2.89B | +31.5% | +3321.0% | +215.7% | +56.5% | |
| Quarterly Shareholders Equity | $21.74B | +7.3% | +15.7% | +112.8% | +17.7% | |
| Quarterly ROA | 10.09% | +50.8% | +110.2% | +97.1% | +17.3% |
Quarterly ROE Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | 42.84% | at high | |
| 3Y | 60.05% | -28.7% | |
| 5Y | 60.05% | -28.7% | |
| All | 254.79% | -83.2% |
Quarterly ROE Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | 22.05% | N/A | +94.3% |
| 3Y | 21.43% | +99.9% | |
| 5Y | 18.51% | +131.4% | |
| All | 1.24% | +3354.8% |
Quarterly ROE History
FAQ
What is the current quarterly ROE of GSK?
As of today, GSK quarterly ROE is 42.84%
What is GSK quarterly ROE most recent change?
GSK quarterly ROE was up +48.08% on September 1, 2025
What is 1-year change in GSK quarterly ROE?
GSK quarterly ROE is up +99.91% year-over-year
How far is GSK quarterly ROE from its all-time high?
GSK quarterly ROE is currently -83.19% below its historical high of 254.79% set on September 30, 1995
How does GSK quarterly ROE rank versus sector peers?
GSK quarterly ROE is higher than 88.87% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
ROE Formula
ROE = Net Income
Shareholders Equity × 100%
Shareholders Equity × 100%
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1131399/000113139925000007/0001131399-25-000007-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk